Single-arm, phase 2 study of regorafenib plus nivolumab in patients with mismatch repair-proficient (pMMR)/microsatellite stable (MSS) colorectal cancer (CRC).Marwan Fakih, Andrew Scott Paulson, Kanwal Raghav et al.|Journal of Clinical Oncology|2021Cited by 74